Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Open accessThe DOI matches its Crossref record; 135 of the 136 references it cites were found in a registry or an index.
Abstract
The convergence of advances in medical science, human biology, data science, and technology has enabled the generation of new insights into the phenotype known as "diabetes." Increased knowledge of this condition has emerged from populations around the world, illuminating the differences in how diabetes presents, its variable prevalence, and how best practice in treatment varies between populations. In parallel, focus has been placed on the development of tools for the application of precision medicine to numerous conditions. This Consensus Report presents the American Diabetes Association (ADA) Precision Medicine in Diabetes Initiative in partnership with the European Association for the Study of Diabetes (EASD), including its mission, the current state of the field, and prospects for the future. Expert opinions are presented on areas of precision diagnostics and precision therapeutics (including prevention and treatment), and key barriers to and opportunities for implementation of precision diabetes medicine, with better care and outcomes around the globe, are highlighted. Cases where precision diagnosis is already feasible and effective (i.e., monogenic forms of diabetes) are presented, while the major hurdles to the global implementation of precision diagnosis of complex forms of diabetes are discussed. The situation is similar for precision therapeutics, in which the appropriate therapy will often change over time owing to the manner in which diabetes evolves within individual patients. This Consensus Report describes a foundation for precision diabetes medicine, while highlighting what remains to be done to realize its potential. This, combined with a subsequent, detailed evidence-based review (due 2022), will provide a roadmap for precision medicine in diabetes that helps improve the quality of life for all those with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the genetics of type 2 diabetes are poorly understood and under intense investigation in this era of precision medicine (52).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Personalized nutrition by prediction of glycemic responses
Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.001 · Cited by 2,929
Ahlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095
Mahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744
Self-citationGlucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Research works printed but not linked: 1
- Rewers M, Stene LC, Norris JM Chapter 11: Risk factors for type 1 diabetes. In Diabetes in America, 3rd ed Cowie CC, Casagrande SS, Menke A,, Eds. Bethesda, MD, National Institutes of Health, 2018
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Quattrin, T., Mastrandrea, L. D., & Walker, L. S. K. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00223-4 · Cited by 244
Ke, C., Narayan, K. M. V., Chan, J. C. N., Jha, P., & Shah, B. R. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00669-4 · Cited by 239
Tobias, D. K., Merino, J., Ahmad, A., Aiken, C., Benham, J. L., Bodhini, D., Clark, A. L., Colclough, K., Corcoy, R., Cromer, S. J., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02502-5 · Cited by 217
New clinical trial design in precision medicine: discovery, development and direction
Duan, X.-P., Qin, B.-D., Jiao, X.-D., Liu, K., Wang, Z., & Zang, Y.-S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01760-0 · Cited by 197
Insulin resistance in type 2 diabetes mellitus
Accili, D., Deng, Z., & Liu, Q. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01114-y · Cited by 163
Singh, A., Shadangi, S., Gupta, P. K., & Rana, S. (2025) · Comprehensive Physiology · doi:10.1002/cph4.70003 · Cited by 163
Epigenetics of type 2 diabetes mellitus and weight change — a tool for precision medicine?
Ling, C., Bacos, K., & Rönn, T. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00671-w · Cited by 161
A scoping review of artificial intelligence-based methods for diabetes risk prediction
Mohsen, F., Al-Absi, H. R. H., Yousri, N. A., El Hajj, N., & Shah, Z. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00933-5 · Cited by 125
Riddle, M. C., Philipson, L. H., Rich, S. S., Carlsson, A., Franks, P. W., Greeley, S. A. W., Nolan, J. J., Pearson, E. R., Zeitler, P. S., & Hattersley, A. T. (2020) · Diabetes Care · doi:10.2337/dci20-0065 · Cited by 117
Self-citationPhenotypic and genetic classification of diabetes
Deutsch, A. J., Ahlqvist, E., & Udler, M. S. (2022) · Diabetologia · doi:10.1007/s00125-022-05769-4 · Cited by 108
Diabetes in China: epidemiology, pathophysiology and multi-omics
Jia, W., Chan, J. C. N., Wong, T. Y., & Fisher, E. B. (2025) · Nature Metabolism · doi:10.1038/s42255-024-01190-w · Cited by 118
Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors
Giandalia, A., Giuffrida, A. E., Gembillo, G., Cucinotta, D., Squadrito, G., Santoro, D., & Russo, G. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115808 · Cited by 121
Nolan, J. J., Kahkoska, A. R., Semnani‐Azad, Z., Hivert, M., Ji, L., Mohan, V., Eckel, R. H., Philipson, L. H., Rich, S. S., Gruber, C., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2216 · Cited by 98
Zhu, D., Li, X., Ma, J., Zeng, J., Gan, S., Dong, X., Yang, J., Lin, X., Cai, H., Song, W., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01802-6 · Cited by 97
Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes
Leslie, R. D., Ronald, C. W., Franks, P. W., Nadeau, K. J., Pearson, E. R., & REDONDO, M. J. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00159-6 · Cited by 121
Nadolsky, K., Addison, B., Agarwal, M., Almandoz, J. P., Bird, M. D., DeGeeter Chaplin, M., Garvey, W. T., & Kyle, T. K. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.03.272 · Cited by 86
Obstructive Sleep Apnea and Cardiometabolic Disease: Obesity, Hypertension, and Diabetes
Tasali, E., Pamidi, S., Covassin, N., & Somers, V. K. (2025) · Circulation Research · doi:10.1161/circresaha.125.325676 · Cited by 122
Precision diabetes: Lessons learned from maturity‐onset diabetes of the young (MODY)
Tosur, M., & Philipson, L. H. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13860 · Cited by 111
Metwally, A. A., Perelman, D., Park, H., Wu, Y., Jha, A., Sharp, S. A., Celli, A., Ayhan, E. M., Abbasi, F., Gloyn, A. L., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01311-6 · Cited by 119
Sisk, B. A., Antes, A. L., Burrous, S., & DuBois, J. M. (2020) · Children · doi:10.3390/children7090145 · Cited by 70
Shields, B. M., Dennis, J., Angwin, C. D., Warren, F. C., Henley, W., Farmer, A. A., Sattar, N. A., Holman, R. R., Jones, A. G., Pearson, E. R., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02120-7 · Cited by 76
Zeng, Z., Huang, S., & Sun, T. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00922-x · Cited by 78
The role of sulfonylureas in the treatment of type 2 diabetes
Tomlinson, B., Patil, N. G., Fok, M., Chan, P., & Lam, C. W. K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1999413 · Cited by 79
2023 Guidelines on the management of patients with diabetes - a position of Diabetes Poland
Araszkiewicz, A., Bandurska-Stankiewicz, E. M., Borys, S., Budzynski, A. Z., Cyganek, K., Cypryk, K., Czech, A., Czupryniak, L., Drzewoski, J., Dzida, G. J., et al. (2023) · Current Topics in Diabetes · doi:10.5114/ctd/160061 · Cited by 85
Implementation of a liver health check in people with type 2 diabetes
Abeysekera, K. W. M., Valenti, L., Younossi, Z., Dillon, J. F., Allen, A. M., Noureddin, M., Rinella, M. E., Tacke, F., Francque, S., Ginès, P., et al. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(23)00270-4 · Cited by 63
Adult-onset autoimmune diabetes
Buzzetti, R., Maddaloni, E., Gaglia, J. L., Leslie, R. D., Wong, F. S., & Boehm, B. O. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00390-6 · Cited by 71
Sivaprasad, S., Wong, T. Y., Gardner, T. W., Sun, J. K., & Bressler, N. M. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00646-x · Cited by 77
Ludvigsson, J., Sumnik, Z., Pelikanova, T., Nattero Chavez, L., Lundberg, E., Rica, I., Martínez-Brocca, M. A., Ruiz de Adana, M., Wahlberg, J., Katsarou, A., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0318 · Cited by 58
Chemello, G., Salvatori, B., Morettini, M., & Tura, A. (2022) · Biosensors · doi:10.3390/bios12110985 · Cited by 70
Mutations and variants of ONECUT1 in diabetes
Philippi, A., Heller, S., Costa, I. G., Senée, V., Breunig, M., Li, Z., Kwon, G., Russell, R., Illing, A., Lin, Q., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01502-7 · Cited by 59
Brazeau, A.-S., Messier, V., Talbo, M. K., Gagnon, C., Taleb, N., Fortier, I., Wu, Z., Perkins, B. A., Carpentier, A. C., Bandini, A., et al. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.05.010 · Cited by 53
Dennis, J., Young, K., McGovern, A. P., Mateen, B. A., Vollmer, S. J., Simpson, M. D., Henley, W., Holman, R. R., Sattar, N. A., Pearson, E. R., et al. (2022) · The Lancet Digital Health · doi:10.1016/s2589-7500(22)00174-1 · Cited by 62
Common metabolic features of hypertension and type 2 diabetes
Usui, I. (2023) · Hypertension Research · doi:10.1038/s41440-023-01233-x · Cited by 63
Lugner, M., Gudbjörnsdottir, S., Sattar, N., Svensson, A.-M., Miftaraj, M., Eeg-Olofsson, K., Eliasson, B., & Franzén, S. (2021) · Diabetologia · doi:10.1007/s00125-021-05485-5 · Cited by 52
Exploring the dual character of metformin in Alzheimer's disease
Ning, P., Luo, A., Mu, X. L., Xu, Y., & Li, T. X. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.108966 · Cited by 53
Precision medicine for cardiometabolic disease: a framework for clinical translation
Franks, P. W., Cefalu, W. T., Dennis, J., Florez, J. C., Mathieu, C., Morton, R. W., Ridderstråle, M., Sillesen, H. H., & Stehouwer, C. D. A. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00165-1 · Cited by 66
Ahmad, A., Lim, L., Morieri, M. L., Tam, C. H. T., Cheng, F., Chikowore, T., Dudenhöffer‐Pfeifer, M., Fitipaldi, H., Huang, C., Kanbour, S., et al. (2024) · Communications Medicine · doi:10.1038/s43856-023-00429-z · Cited by 84
Identification of biomarkers for glycaemic deterioration in type 2 diabetes
Slieker, R. C., Donnelly, L. A., Akalestou, E., López–Noriega, L., Melhem, R., Güneş, A., Azar, F. A., Efanov, A. M., Georgiadou, E., Muniangi-Muhitu, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38148-7 · Cited by 57
Autoantibody-Negative Type 1 Diabetes: A Neglected Subtype
Patel, S., Ma, C. S., Fourlanos, S., & Greenfield, J. R. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.02.001 · Cited by 53
Ferstad, J. O., Vallon, J. J., Jun, D., Gu, A., Vitko, A., Morales, D. P., Leverenz, J., Lee, M. Y., Leverenz, B., Vasilakis, C., et al. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13256 · Cited by 46
Tura, A., Grespan, E., Göbl, C. S., Koivula, R. W., Franks, P. W., Pearson, E. R., Walker, M., Forgie, I. M., Giordano, G. N., Pavo, I. J., et al. (2021) · Diabetes · doi:10.2337/db21-0227 · Cited by 54
Martelli, E., Enea, I., Zamboni, M., Federici, M., Bracale, U. M., Sangiorgi, G., Martelli, A. R., Messina, T., & Settembrini, A. M. (2023) · Diagnostics · doi:10.3390/diagnostics13142356 · Cited by 46
van Baar, A. C. G., Deviere, J. M. E., Hopkins, D., Crenier, L., Holleman, F., Neto, M. G., Becerra, P., Vignolo, P., Grunert, L. R., Mingrone, G., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109194 · Cited by 46
Nayak, S. P. R. R., Haridevamuthu, B., Murugan, R., Dhivya, L. S., Venkatesan, S., Almutairi, M. H., Almutairi, B. O., Kathiravan, M. K., Namasivayam, S. K. R., & Arockiaraj, J. (2024) · Process Biochemistry · doi:10.1016/j.procbio.2024.04.012 · Cited by 45
Insulin: evolution of insulin formulations and their application in clinical practice over 100 years
Bolli, G. B., CHENG, A. Y. Y., & Owens, D. R. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01938-4 · Cited by 58
The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion
Murphy, R., Colclough, K., Pollin, T. I., Iklé, J. M., Svalastoga, P., Maloney, K. A., Saint‐Martin, C., Molnes, J., PMDI, A., Tobias, D. K., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00369-8 · Cited by 59
Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklist
Lim, S. S., Semnani‐Azad, Z., Morieri, M. L., Ng, A., Ahmad, A., Fitipaldi, H., Boyle, J. A., Collin, C., Dennis, J., Langenberg, C., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03033-3 · Cited by 47
Luo, A., Ning, P., Lu, H., Huang, H., Shen, Q., Zhang, D., Xu, F., Yang, L. J., & Xu, Y. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220180 · Cited by 45
Antidiabetic Properties of Plant Secondary Metabolites
Сухих, С. А., Babich, O., Prosekov, A. Y., Kalashnikova, O. B., Носкова, С., Bakhtiyarova, A., Krol, O., Tsvetkova, E. V., & Ivanova, S. A. (2023) · Metabolites · doi:10.3390/metabo13040513 · Cited by 63
El‐Achkar, T. M., Eadon, M. T., Kretzler, M., Himmelfarb, J., Lake, B. B., Zhang, K., Lecker, S. H., Morales, A., Bogen, S. A., Amodu, A., et al. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.08.015 · Cited by 49
The Potential Roles of Post-Translational Modifications of PPARγ in Treating Diabetes
Ji, X., Zhang, W., Yin, L., Shi, Z., Luan, J., Chen, L., & Liu, L. (2022) · Biomolecules · doi:10.3390/biom12121832 · Cited by 42
Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children
SHAH, A. S., Nadeau, K. J., Dabelea, D., & REDONDO, M. J. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042120-012033 · Cited by 39
Defining and Classifying New Subgroups of Diabetes
Balasubramanyam, A. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-050219-034524 · Cited by 41
Genome-wide polygenic risk score for retinopathy of type 2 diabetes
Forrest, I. S., Chaudhary, K., Paranjpe, I., Vy, H. M. T., Márquez‐Luna, C., Rocheleau, G., Saha, A., Chan, L., Vleck, T. T. V., Loos, R. J. F., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab067 · Cited by 38
Subtypes of gestational diabetes and future risk of pre-diabetes or diabetes
Retnakaran, R. R., Chang, Y. R., Hanley, A. J., Connelly, P. W., Sermer, M., & Zinman, B. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101087 · Cited by 41
Formichi, C., Fignani, D., Nigi, L., Grieco, G. E., Brusco, N., Licata, G., Sabato, C., Ferretti, E., Sebastiani, G., & Dotta, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179454 · Cited by 38
Big data and machine learning to tackle diabetes management
Pina, A. F., Meneses, M. J., Sousa‐Lima, I., Henriques, R., Raposo, J. F., & Macedo, M. P. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13890 · Cited by 40
Shiferaw, M., & Kassahun, W. D. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12267 · Cited by 52
Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin
Chan, J. C. N., Yang, A., Chu, N. H. S., & Chow, E. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15700 · Cited by 38
Cefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., & Rosenblum, N. D. (2021) · Diabetes Care · doi:10.2337/dci21-0051 · Cited by 40
Attitudes on Artificial Intelligence use in Pediatric Care From Parents of Hospitalized Children
Haley, L. C., Boyd, A. K., Hebballi, N. B., Reynolds, E. W., Smith, K. G., Scully, P. T., Nguyen, T., Bernstam, E. V., & Li, L. T. (2023) · Journal of Surgical Research · doi:10.1016/j.jss.2023.10.027 · Cited by 33
Person‐reported outcomes in diabetes care: What are they and why are they so important?
Hermanns, N., Kulzer, B., & Ehrmann, D. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15471 · Cited by 36
Petrelli, A., Giovenzana, A., Insalaco, V., Phillips, B. E., Pietropaolo, M., & Giannoukakis, N. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01430-3 · Cited by 32
Zhu, M., Li, Y. H., Luo, B., Cui, J., Liu, Y., & Liu, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.861110 · Cited by 45
Al-Kuraishy, H. M., Al-Gareeb, A. I., Albogami, S. M., Sabatier, J., Nadwa, E. H., Hafiz, A. A., Negm, W. A., Kamal, M., Al-Jouboury, M., Elekhnawy, E., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15111361 · Cited by 41
Menzen, M., Berentzen, T. L., Catarig, A.-M., Pieperhoff, S., Simon, J., & Jacob, S. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2007-2061 · Cited by 29
Thakur, J. S., & Nangia, R. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.768471 · Cited by 31
Bodhini, D., Morton, R. W., Santhakumar, V., Nakabuye, M., Pomares‐Millan, H., Clemmensen, C., Fitzpatrick, S. L., Guasch‐Ferré, M., Pankow, J. S., Ried‐Larsen, M., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00363-0 · Cited by 35
REDONDO, M. J., & Balasubramanyam, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab545 · Cited by 35
Prediction Models for Type 2 Diabetes Progression: A Systematic Review
Nazirun, N. N. N., Wahab, A. A., Selamat, A., Fujita, H., Krejcar, O., Kuča, K., & Gan, H. (2024) · IEEE Access · doi:10.1109/access.2024.3432118 · Cited by 45
Carollo, C., Sorce, A., Cirafici, E., Mulè, G., & Caimi, G. (2025) · Nutrients · doi:10.3390/nu17071212 · Cited by 28
Precision treatment of beta-cell monogenic diabetes: a systematic review
Naylor, R. N., Patel, K., Kettunen, J. L. T., Männistö, J. M. E., Støy, J., Beltrand, J., Polak, M., PMDI, A., Tobias, D. K., Merino, J., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00556-1 · Cited by 46
Scarale, M. G., Mastroianno, M., Prehn, C. P., Copetti, M., Salvemini, L., Adamski, J., Cosmo, S. D., Trischitta, V., & Menzaghi, C. (2022) · Diabetes · doi:10.2337/db22-0095 · Cited by 26
Bellido, V., Padín, C. A., Catarig, A., Clark, A., Pittol, S. B., & Delgado, E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11174938 · Cited by 24
Lim, S. S., Takele, W. W., Vesco, K. K., Redman, L. M., Hannah, W., Bonham, M. P., Chen, M., Chivers, S. C., Fawcett Andrea, J., Grieger, J. A., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00366-x · Cited by 37
Genetics of Type 2 Diabetes: Opportunities for Precision Medicine
Kim, D. S., Gloyn, A. L., & Knowles, J. W. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.03.346 · Cited by 27
Glucagon-Like Peptide 1 Receptor Agonists and Asthma Exacerbations: Which Patients Benefit Most?
Wang, T., Keil, A. P., Buse, J. B., Keet, C. A., Kim, S., Wyss, R., Pate, V., Jonsson‐Funk, M. L., Pratley, R. E., Kvist, K., et al. (2024) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202309-836oc · Cited by 25
Diabetes and obesity: leveraging heterogeneity for precision medicine
Franks, P. W., & Sargent, J. L. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae746 · Cited by 28
Li, H., Yang, S., Fan, L., Luo, L., Lei, W., Tan, P., Yue, T., & Gao, Z. (2023) · Food Frontiers · doi:10.1002/fft2.294 · Cited by 23
Lessons and Applications of Omics Research in Diabetes Epidemiology
Yu, G., Tam, H. C. H., Huang, C., Shi, M., Lim, C. K. P., Chan, J. C. N., & Ronald, C. W. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01533-7 · Cited by 24
Harnessing Pharmacomultiomics for Precision Medicine in Diabetes: A Comprehensive Review
Dhieb, D., Mustafa, D. N., Hassiba, M., Alasmar, M., Elsayed, M. E. M., Musa, A., Zirie, M. A., & Bastaki, K. (2025) · Biomedicines · doi:10.3390/biomedicines13020447 · Cited by 28
Cefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., & Rosenblum, N. D. (2021) · Diabetes · doi:10.2337/db21-0777 · Cited by 22
Al‐Sari, N., Kutuzova, S., Suvitaival, T., Henriksen, P., Pociot, F., Rossing, P. R., McCloskey, D., & Legido‐Quigley, C. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104032 · Cited by 23
Zou, X., Huang, Q., Luo, Y., Ren, Q., Han, X., Zhou, X., & Ji, L. (2022) · Diabetologia · doi:10.1007/s00125-022-05748-9 · Cited by 22
A novel splice-affecting HNF1A variant with large population impact on diabetes in Greenland
Thuesen, A. C. B., Stæger, F. F., Kaci, A., Solheim, M. H., Aukrust, I., Jørsboe, E., Santander, C. G., Andersen, M. K., Li, Z., Gilly, A., et al. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100529 · Cited by 23
A Research Roadmap to Address the Heterogeneity of Diabetes and Advance Precision Medicine
Franks, P. W., Rich, S. S., Linder, B. L., Zaghloul, N. A., & Cefalu, W. T. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae844 · Cited by 23
Manzini, E., Vlacho, B., Franch‐Nadal, J., Escudero, J., Génova, A., Reixach, E., Andrés, E., Pizarro, I., Portero, J. L., Mauricio, D., et al. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104218 · Cited by 32
Li, J. H., Brenner, L. N., Kaur, V., Figueroa, K., Schroeder, P. H., Huerta‐Chagoya, A., MaGiC Investigators, Chen, J., Spracklen, C. N., Marenne, G., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05922-7 · Cited by 20
Internet of Things and Bigdata Analytics in Preventive Healthcare: A Synthetic Review
Šajnović, U., Vošner, H. B., Završnik, J., Žlahtič, B., & Kokol, P. (2024) · doi:10.20944/preprints202408.0445.v1 · Cited by 19
Polu, P. R., Mishra, S., Gupta, J., Vyas, M., & Babu, M. R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01996-4 · Cited by 27
Magkos, F., Reeds, D. N., & Mittendorfer, B. (2022) · Physiological Reviews · doi:10.1152/physrev.00015.2022 · Cited by 21
Etiology and Pathophysiology of Diabetes Mellitus in Dogs
O’Kell, A. L., & Davison, L. J. (2023) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2023.01.004 · Cited by 23
Metadata
- Authors
- Chung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., Philipson, L., McElvaine, A. T., Cefalu, W. T., Rich, S. S., & Franks, P. W.
- Affiliations
- Columbia University Irving Medical Center (US)
- American Diabetes Association (US)
- Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA
- University of Exeter (GB)
- Harvard University (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Centre for Human Genetics (GB)
- Trinity College Dublin (IE)
- Colorado School of Public Health (US)
- University of Dundee (GB)
- University of Chicago (US)
- Duke University (US)
- University of Virginia (US)
- Corresponding author
- Franks, Paul W.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-06-11
- Volume
- 43
- Issue
- 7
- Pages
- 1617-1635
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC7305007
- OpenAlex
- W3036199105
- Cited by
- 400
- References
- 136
- Citations by year
- 2026: 50 · 2025: 57 · 2024: 74 · 2023: 92 · 2022: 72 · 2021: 47 · 2020: 8
- FWCI
- 41.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion, public-domain)
- Funders
- American Diabetes Association (1-15-ACE-26)
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Regeneron Pharmaceuticals
- Wellcome Trust (212259, 098381, 098395, 098395/Z/12/Z, 203141, 102820/Z/13/Z)
- National Institute for Health and Care Research (NF-SI-0611-10219, NF-SI-0617-10090)
- European Commission (115317, 115881, 875534, 098381)
- Lunds Universitet
- Novo Nordisk
- Vetenskapsrådet
- Universitetet i Bergen
- Servier
- National Institutes of Health (5r21ai142483-02, DK26687, UL1TR001873)
- Genentech
- Medical Research Council (MR/K005707/1, MR/T032014/1)
- National Institute of Allergy and Infectious Diseases (R21-AI142483)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-26687, R01DK104942, 212259, R01DK052431, R01DK122586, U01DK105535, DP3DK111906, DK 26687, DK104351, R01DK104351, DK122586, 098381, 203141, P30DK026687, U54DK118612, P30DK020595, DK-52431)
- National Center for Advancing Translational Sciences
- Janssen Pharmaceuticals
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD094150)
- University of Colorado School of Medicine, Anschutz Medical Campus
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- precision medicine, diabetes mellitus, precision diagnostics, precision therapy, monogenic diabetes, diabetes prevention, diabetes treatment, implementation barriers, personalized medicine, diabetes phenotypes
- MeSH terms
- Diabetes Mellitus, Endocrinology, Europe, Financial Management, Health Plan Implementation, Humans, Practice Patterns, Physicians', Quality of Life, Societies, Medical, United States, Evidence-Based Medicine, Consensus, Biomedical Research, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.